Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain

Molecular Brain Research

Volumn 138, Issue 1, 2005, Pages 24-34

  Wang, Rui ^a   Boules, Mona ^b   Gollatz, Elisa ^b   Williams, Katrina ^b   Tiner, William ^b   Richelson, Elliott ^b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b MAYO CLINIC   (United States)

Author keywords

mRNA; Neurotensin agonist; Neurotensin receptors; Rat; Tolerance; Tyrosine hydroxylase

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; MESSENGER RNA; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR AGONIST; NT 69 L; NUCLEAR RECEPTOR RELATED FACTOR 1; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL NETWORK; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIAQUEDUCTAL GRAY MATTER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BRAIN; CELL COUNT; DNA-BINDING PROTEINS; DOPA DECARBOXYLASE; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NEUROTENSIN; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, NEUROTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 22744434151     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.03.014     Document Type: Article

References (50)

1. T. Antonelli, M.C. Tomasini, S. Finetti, L. Giardino, L. Calza, K. Fuxe, P. Soubrie, S. Tanganelli, and L. Ferraro Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture J. Neurosci. Res. 70 2002 766 773
2. E.B. Binder, B. Kinkead, M.J. Owens, and C.B. Nemeroff Neurotensin and dopamine interactions Pharmacol. Rev. 53 2001 453 486
3. G. Bissette, C.B. Nemeroff, P.T. Loosen, A.J. Prange, and M.A. Lipton Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin Nature 262 1976 607 609
4. M. Boules, B. Cusack, L. Zhao, A. Fauq, D.J. McCormick, and E. Richelson A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents Brain Res. 865 2000 35 44
5. M. Boules, B. McMahon, L. Warrington, J. Stewart, J. Jackson, A. Fauq, D. McCormick, and E. Richelson Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties Brain Res. 919 2001 1 11
6. M. Boules, L. Warrington, A. Fauq, D. McCormick, and E. Richelson Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats Eur. J. Pharmacol. 428 2001 227 233
7. M. Boules, P. Fredrickson, and E. Richelson Current topics: brain penetrating neurotensin analog Life Sci. 73 2003 2785 2792
8. M. Boules, B. McMahon, R. Wang, L. Warrington, J. Stewart, S. Yerbury, A. Fauq, D. McCormick, and E. Richelson Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier Brain Res. 987 2003 39 48
9. R. Carraway, and S.E. Leeman The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami J. Biol. Chem. 248 1973 6854 6861
10. B.V. Clineschmidt, J.C. McGuffin, and P.B. Bunting Neurotensin: antinocisponsive action in rodents Eur. J. Pharmacol. 54 1979 129 139
11. B. Cusack, M. Boules, B.M. Tyler, A. Fauq, D.J. McCormick, and E. Richelson Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol Brain Res. 856 2000 48 54
12. P.R. Dobner, A.Y. Deutch, and J. Fadel Neurotensin: dual roles in psychostimulant and antipsychotic drug responses Life Sci. 73 2003 801 811
13. B.M. Faggin, and L.X. Cubeddu Rapid desensitization of dopamine release induced by neurotensin and neurotensin fragments J. Pharmacol. Exp. Ther. 253 1990 812 818
14. A. Fassio, G. Evans, R. Grisshammer, J.P. Bolam, M. Mimmack, and P.C. Emson Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody Neuropharmacology 39 2000 1430 1442
15. A.H. Fauq, F. Hong, B. Cusack, B.M. Tyler, Y.P. Pang, and E. Richelson Synthesis of (2S)-2-amino-3-(1H-4-indolyl) propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides Tetrahedron: Asymmetry 9 1998 4127 4134
16. P. Fredrickson, M. Boules, S. Yerbury, and E. Richelson Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats Eur. J. Pharmacol. 458 2003 111 118
17. D.L. Garver, G. Bissette, J.K. Yao, and C.B. Nemeroff Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients Am. J. Psychiatry 148 1991 484 488
18. J.A. Gilbert, T.R. Strobel, and E. Richelson Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115 Biochem. Pharmacol. 37 1988 2833 2838
19. J.E. Grisel, L.R. Watkins, and S.F. Maier Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord Psychopharmacology (Berlin) 128 1996 248 255
20. D. Gully, B. Labeeuw, R. Boigegrain, F. Oury-Donat, A. Bachy, M. Poncelet, R. Steinberg, M.F. Suaud-Chagny, V. Santucci, N. Vita, F. Pecceu, C. Labbe-Jullie, P. Kitabgi, P. Soubrie, G. Le Fur, and J.P. Maffrand Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist J. Pharmacol. Exp. Ther. 280 1997 802 812
21. M. Heaulme, R. Leyris, G. Le Fur, and P. Soubrie Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization Neuropharmacology 36 1997 1447 1454
22. B. Kinkead, E.B. Binder, and C.B. Nemeroff Does neurotensin mediate the effects of antipsychotic drugs? Biol. Psychiatry 46 1999 340 351
23. P. Kitabgi, W. Rostene, M. Dussaillant, A. Schotte, P.M. Laduron, and J.P. Vincent Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution Eur. J. Pharmacol. 140 1987 285 293
24. P. Kitabgi, F. De Nadai, C. Labbe-Jullie, I. Dubuc, D. Nouel, J. Costentin, Y. Masuo, W. Rostene, J. Woulfe, and L. Lafortune Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n Clin. Neuropharmacol. 15 Suppl. 1 (Pt. A) 1992 313A 314A
25. F. Le, B. Cusack, and E. Richelson The neurotensin receptor: is there more than one subtype? Trends Pharmacol. Sci. 17 1996 1 3
26. A.H. Li, T.H. Yeh, P.P. Tan, H.M. Hwang, and H.L. Wang Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms Neuropharmacology 40 2001 1073 1083
27. A.J. Morin, M. Tajani, B.E. Jones, and A. Beaudet Spatial relationship between neurotensinergic axons and cholinergic neurons in the rat basal forebrain: a light microscopic study with three-dimensional reconstruction J. Chem. Neuroanat. 10 1996 147 156
28. C.B. Nemeroff Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiatry 15 1980 283 302
29. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates Third ed. 1997 Academic Press, Inc. San Francisco
30. D.J. Pettibone, J.F. Hess, P.J. Hey, M.A. Jacobson, M. Leviten, E.V. Lis, P.J. Mallorga, D.M. Pascarella, M.A. Snyder, J.B. Williams, and Z. Zeng The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin J. Pharmacol. Exp. Ther. 300 2002 305 313
31. V.M. Pickel, J. Chan, K.T. Delle Donne, H. Boudin, D. Pelaprat, and W. Rostene High-affinity neurotensin receptors in the rat nucleus accumbens: subcellular targeting and relation to endogenous ligand J. Comp. Neurol. 435 2001 142 155
32. C. Pothoulakis, I. Castagliuolo, and S.E. Leeman Neuroimmune mechanisms of intestinal responses to stress. Role of corticotropin-releasing factor and neurotensin Ann. N. Y. Acad. Sci. 840 1998 635 648
33. F. Rioux, R. Kerouac, R. Quirion, and S. St-Pierre Mechanisms of the cardiovascular effects of neurotensin Ann. N. Y. Acad. Sci. 400 1982 56 74
34. W. Rostene, A. Brouard, C. Dana, Y. Masuo, F. Agid, M. Vial, A.M. Lhiaubet, and D. Pelaprat Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence Ann. N. Y. Acad. Sci. 668 1992 217 231
35. P. Sarret, A. Beaudet, J.P. Vincent, and J. Mazella Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain J. Comp. Neurol. 394 1998 344 356
36. P. Sarret, L. Gendron, P. Kilian, H.M. Nguyen, N. Gallo-Payet, M.D. Payet, and A. Beaudet Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells J. Biol. Chem. 277 2002 36233 36243
37. P. Sarret, P. Krzywkowski, L. Segal, M.S. Nielsen, C.M. Petersen, J. Mazella, T. Stroh, and A. Beaudet Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system J. Comp. Neurol. 461 2003 483 505
38. J. Smith The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia Psychoneuroendocrinology 11 1986 15 37
39. J. Smith Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization Brain Res. 979 2003 245 248
40. F. Souaze Maintaining cell sensitivity to G-protein coupled receptor agonists: neurotensin and the role of receptor gene activation J. Neuroendocrinol. 13 2001 473 479
41. S.A. Tershner, and F.J. Helmstetter Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray Brain Res. 865 2000 17 26
42. B.M. Tyler, D.J. McCormick, C.V. Hoshall, C.L. Douglas, K. Jansen, B.W. Lacy, B. Cusack, and E. Richelson Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo FEBS Lett. 421 1998 280 284
43. B.M. Tyler, C.L. Douglas, A. Fauq, Y.P. Pang, J.A. Stewart, B. Cusack, D.J. McCormick, and E. Richelson In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier Neuropharmacology 38 1999 1027 1034
44. B.M. Tyler, K. Jansen, D.J. McCormick, C.L. Douglas, M. Boules, J.A. Stewart, L. Zhao, B. Lacy, B. Cusack, A. Fauq, and E. Richelson Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression Proc. Natl. Acad. Sci. U. S. A. 96 1999 7053 7058
45. B. Tyler-McMahon, J.A. Stewart, F. Farinas, D.J. McCormick, and E. Richelson A highly potent neurotensin analog that crosses the blood brain barrier and causes hypothermia and antinociception Eur. J. Pharm. 390 2000 107 111
46. J.P. Vincent Neurotensin receptors. Binding properties, transduction mechanisms, and purification Ann. N. Y. Acad. Sci. 668 1992 90 100
47. J.P. Vincent, J. Mazella, and P. Kitabgi Neurotensin and neurotensin receptors Trends Pharmacol. Sci. 20 1999 302 309
48. N. Walker, I. Lepee-Lorgeoux, J. Fournier, C. Betancur, W. Rostene, P. Ferrara, and D. Caput Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain Brain Res. Mol. Brain Res. 57 1998 193 200
49. M.B. Wang Rui, W. Tiner, and E. Richelson Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro Brain Res. 1025 2004 21 28
50. E. Widerlov, L.H. Lindstrom, G. Besev, P.J. Manberg, C.B. Nemeroff, G.R. Breese, J.S. Kizer, and A.J. Prange Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment Am. J. Psychiatry 139 1982 1122 1126